Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a <scp>post‐hoc</scp> analysis of the <scp>ATHENA</scp> trial-Reference-Cited by-同舟云学术

Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial

Published:2022-04-10 Issue:6 Volume:24 Page:1094-1101
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Vaduganathan Muthiah¹,Piccini Jonathan P.²,Camm A. John³,Crijns Harry J.G.M.⁴,Anker Stefan D.⁵,Butler Javed⁶,Stewart John⁷,Braceras Rogelio⁸,Albuquerque Alessandro P.A.⁸,Wieloch Mattias⁹¹⁰,Hohnloser Stefan H.¹¹

Affiliation:

1. Division of Cardiovascular Medicine Brigham and Women's Hospital and Harvard Medical School Boston MA USA

2. Duke University Medical Center and the Duke Clinical Research Institute Durham NC USA

3. Cardiology Clinical Academic Group Molecular & Clinical Sciences Institute St George's University of London London UK

4. Maastricht University Medical Center Maastricht The Netherlands

5. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT) German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin Berlin Germany

6. Department of Medicine University of Mississippi Jackson MS USA

7. Sanofi, Laval Quebec Canada

8. Sanofi Bridgewater NJ USA

9. Sanofi Paris France

10. Department of Coagulation Disorders, Skåne University Hospital Lund University Malmö Sweden

11. Division of Clinical Electrophysiology, Department of Cardiology J. W. Goethe University Frankfurt Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2487

Reference27 articles.

1. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

2. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

3. High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea

4. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction

5. Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resurrection of classical antiarrhythmic drugs;International Journal of Cardiology;2024-10

2. Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction;JACC: Heart Failure;2024-09

3. Contemporary treatment options in heart failure with preserved ejection fraction;European Heart Journal - Cardiovascular Imaging;2024-08-22

4. 2024 update in heart failure;ESC Heart Failure;2024-05-28

5. Cardiac-Targeting Peptide: From Discovery to Applications;Biomolecules;2023-11-23